VSee Health, Inc. Total Liabilities
VSee Health, Inc. (VSEE) had Total Liabilities of $9.14 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-14
- 2026-06-30: Liabilities $9.14M.
- 2026-03-31: Liabilities $12.70M.
- 2025-12-31: Liabilities $16.96M.
- 2025-09-30: Liabilities $24.28M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $9.14M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $12.70M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $16.96M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $24.28M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $23.95M 10-Q/A · filed 2025-11-20 | $23.95M 10-Q · filed 2025-10-15 |
| 2025-03-31 | $22.89M 10-Q · filed 2025-10-15 | |
| 2024-12-31 | $20.01M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $21.37M 10-Q · filed 2025-11-14 | $20.27M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $25.48M 10-Q/A · filed 2025-11-20 | $24.18M 10-Q · filed 2024-09-23 |
| 2024-03-31 | $5.64M 10-Q · filed 2025-10-15 | $13.34M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $5.11M 10-K/A · filed 2025-08-29 | $12.35M 10-K · filed 2024-04-12 |
| 2023-09-30 | $5.04M 10-K/A · filed 2025-08-29 | $9.39M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $9.41M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $3.92M 10-K/A · filed 2025-08-29 | $9.38M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.67M 10-K · filed 2024-04-12 | |
| 2022-09-30 | $5.92M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.01M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $4.76M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $4.55M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |